Early drug intervention may help Multiple Sclerosis patients
FRESNO, Calif. (KFSN) -- New research reveals that early drug intervention may slow progression of Multiple Sclerosis (MS).
MS is an auto-immune disease that attacks the brain and spinal cord. Patients suffer attacks that impact muscles, vision, and even personality.
New research by the American Academy of Neurology finds that early use of a new drug could slow the progression of the disease. The drug is called Interferon Beta 1A.
In a three-year trial patients who were given the drug were less likely to develop late-stage MS.
- Valley schools prepare for new transgender law
- The new year will mean a new sheriff for Merced County
- Ex-BP engineer convicted on 1 obstruction charge
- Marijuana was target of Fresno Co home invasion
- Kai was neither hero nor did he cause crash, witnesses say
- Scams can include investments with friends
- Jury awards $1.5 million in Fresno Police excessive force trial
- Valley growers told to brace for drought
- Gunman kills himself, 1 other at Reno hospital
- Toys for Tots needs just over 10k gifts to meet goal
- Tulare County opens fraud hotline
- Big Sur wildfire destroys fire chief's home
- Mega Millions jackpot soars to $636 million
- 3 Fresno State Bulldogs named SI All-Americans Honorable Mentions
Most Viewed StoriesMost Viewed Photos